CSRXP: OVERSIGHT REPORT ADDS TO MOMENTUM IN WASHINGTON TO HOLD BIG PHARMA ACCOUNTABLE
U.S. House Oversight & Reform Committee Report Shines Light on Branded… Read More

U.S. House Oversight & Reform Committee Report Shines Light on Branded… Read More
Pharmaceutical Companies Increase Prices on 32 Brand Name Drugs to Start July… Read More
New Report Reveals “Hidden Hand” Of Brand Name Drug Industry In case you… Read More
Pallone and Maloney Announce Joint Investigation into Massive Price Tag on… Read More
Lawmakers Must Advance Solutions to Lower Drug Prices Washington,… Read More
Troubling for Public Health Institution to Depart from Established Norms to… Read More
Campaign Calls for Promises Made to the American People to Lower Prescription… Read More
Time for the Administration and Congress to Convert Promises Made Into… Read More
Administration and Congress Must Work Together To Pass Solutions to Hold Big… Read More
Holding Big Pharma Accountable Remains Top Priority for American Voters… Read More
Congress and the Administration Must Act on Solutions that Have Won Bipartisan… Read More
Lawmakers Pass Pair of Bills Aimed at Boosting Generic and Biosimilar… Read More